ivaltinostat

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug Nameivaltinostat
Drug Alias Nameivaltinostat（CG-745）CG-745Ivaltinostat - CrystalGenomicsCG-200745CG200745 PPA +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsSolid tumoursFibrosisMyelodysplastic Syndromes +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCrystalgenomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrystalgenomics IncMachaon Biotherapeutics IncCG Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursFibrosisMyelodysplastic Syndromes +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A